SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Mamo turns what used to be complex into easy, human-first routines.  It works quietly in the background, finding smart opportunities for your money while you focus on what matters in your life. Think of Mamo as your knowledgeable friend who understands how to help your money grow and explain everything in plain language.  Behind the scenes, Mamo applies proven strategies and real-time data to optimize your portfolio, reinvest earnings when conditions are right, and adapt to market shifts — all with your approval and full transparency.  No noise. No confusion. Just calm, steady growth.

Mamo

MAMO.X is trending as social media buzz points to a potential breakout, with community members highlighting a cup and handle formation. Talk centers around the anticipation of its integration into the Base App and the possibility of new users being exposed to the crypto. Some traders are drawing comparisons to other tokens, while others express excitement about its potential.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU.X is trending as its community rallies around its real-world applications, including merchandise and energy drinks, emphasizing its dedication to building an enduring brand. The community's strong IRL presence and growing holder count are key talking points, with many expressing bullish sentiment about its long-term potential. Despite market fluctuations, the focus remains on community growth and the upcoming new website.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics ($CVKD) is trending as buyers fuel a rally following the company's acquisition of anti-coagulant assets, with bulls eyeing higher highs and breakout energy feeling strong. Community members are discussing the potential for an upside breakout with strong volume as the company advances its pipeline of cardiovascular products. The healthcare technology niche has a thin volume trading.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard ($MA) is trending due to a mix of options activity and broader market analysis, with community members pointing out both bullish and bearish signals. Discussions include unusual options flow, analyst ratings, and potential impacts from tariffs and competition in the payment processing space. Some are questioning if stablecoins or general economic uncertainty will affect MA's long-term growth.

TON Strategy Co. engages in platform development. The firm's Software-as-a-Service (SaaS) platform is based on its proprietary interactive video technology and consists of a suite of sales enablement business software products offered on a subscription basis. The company was founded by Rory J. Cutaia on November 27, 2012 and is headquartered in Las Vegas, NV.

TON Strategy Co.

TON Strategy ($TONX) is trending due to its strategic pivot towards accumulating Toncoin and integrating with Telegram, sparking community debate about its long-term viability and potential within the blockchain ecosystem. While some traders express skepticism and point to the company's past performance, others highlight the potential of leveraging Telegram's massive user base for crypto adoption. Discussions also involve recent share repurchases and insider activity.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks ($ANET) is trending amid ongoing discussions about its potential in the AI-driven data center market, with analysts highlighting strong growth prospects and key partnerships. Community members are actively evaluating entry points and discussing potential upside, particularly given the company's alignment with AI and data center trends. Option activity and analyst target updates contribute to the increased attention on the stock.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck ($MRK) is trending due to a mix of factors, including potential pipeline expansion with its recent acquisition of Verona Pharma and anticipation surrounding its upcoming earnings report. Community discussions also highlight Keytruda's performance and the looming patent expiration, leading to speculation about future acquisitions to bolster their portfolio. Some traders are eyeing potential breakout opportunities above $85.

Kohl's Corp. engages in the operation of family-oriented department stores. Its business line includes apparel, footwear, and accessories for women, men, and children, home products, beauty products, and accessories. The stores generally carry a consistent merchandise assortment with some differences attributable to regional preferences. The company was founded in 1962 and is headquartered in Menomonee Falls, WI.

Kohl`s Corp.

Kohl's Corp

Kohl's is trending as the community discusses potential short squeezes, driven by a high short interest and upcoming dividend payouts. Bullish sentiment is fueled by Citigroup's recent price target increase and observed unusual options activity. Some traders are also pointing to the company's real estate assets and potential for a turnaround, while others highlight the partnership with Sephora as a growth driver.

Freddie Mac engages in the provision of housing finance system solutions. It operates through the Single-Family and Multifamily segments. The Single-Family segment is involved in purchase, securitization, and guarantee of single-family loans, investments, and management of single-family mortgage credit risk and market risk. The Multifamily segment focuses on purchase, securitization, and guarantee of multifamily loans, investments, securities, and management of multifamily mortgage credit risk and market risk. The company was founded on July 24, 1970 and is headquartered in McLean, VA.

Federal Home Loan Mortgage Corp

Freddie Mac

Freddie Mac ($FMCC) is trending as investors react to rising mortgage rates and speculation around a potential IPO. Community discussions revolve around Trump's involvement, the structure of a deal, and potential dilution. Some investors see a buying opportunity, while others are expressing concern regarding conservatorship.

McDonald's Corp. engages in the operation and franchising of restaurants. It operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. The firm's products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, McCafe beverages, and other beverages. The company was founded by Raymond Albert Kroc on April 15, 1955, and is headquartered in Oak Brook, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is trending as traders react to analyst upgrades and potential catalysts like the return of snack wraps. The community is closely watching for a breakout above the $300 resistance level, while also considering potential headwinds like changing consumer spending habits and anti-American sentiment. Discussions also highlight McDonald's efforts to innovate its menu, expand its digital presence, and attract value-conscious customers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Revvity, Inc. (RVTY) CEO Prahlad Singh acknowledged challenges to the company’s immunodiagnostics business in China, owing to changes in regulations, and warned of a pullback during the firm’s earnings call on Monday.The CEO stated that the company began experiencing challenges in its diagnostics business midway through the second quarter, due to a revised lab reimbursement policy tied to Diagnosis-Related Groups (DRGs), which affected the size of diagnostic panels ordered by physicians in the country.Healthcare providers are opting for fewer multiplex diagnostic products, the CEO said, while noting that this trend is likely to drive volume for single-plex tests.“For the remainder of the year, we are now expecting a fairly meaningful pullback in our immunodiagnostics business in China, which is incorporated into our updated outlook for the total company for the year,” Singh said. The immunodiagnostics business in China represents 6% of the company’s total revenue.Shares of the company slid 8% as of Monday afternoon, at the time of writing.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/RVTY">RVTY</a> jumped from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:1358/124;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_28_at_1_30_31_PM_png_4f6a008503.webp" alt="RVTY's Sentiment Meter and Message Volume as of 1:30 p.m. ET on July 28, 2025 | Source: Stocktwits" width="1358" height="124"><figcaption>RVTY's Sentiment Meter and Message Volume as of 1:30 p.m. ET on July 28, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user opined that the drop in stock on Monday is an overreaction, and that it is being overly punished for a change in Chinese regulation.<stembedurl>https://stocktwits.com/Spartan2008/message/622689408</stembedurl>Yet another opined that the change in regulation applies to all companies in the space and that the company has sufficient cash on hand.<stembedurl>https://stocktwits.com/YouOnlyLiveTwice/message/622719140</stembedurl>For the full year 2025, the company has raised its revenue guidance to $2.84 billion to $2.88 billion, reflecting recent changes in foreign currency exchange rates and assuming 2% to 4% organic growth.The company also updated its adjusted earnings per share guidance to a range of $4.85 to $4.95, down from its previous guidance of $4.90 to $5.For the second quarter, the company’s revenue came in at $720 million, marking a 4% growth and exceeding an analyst estimate of $711.33 million, according to data from Fiscal AI.Adjusted earnings per share for the quarter came in at $1.18, compared to $1.22 in the corresponding period of 2024, but above an expected $1.14.RVTY stock is down by 14% this year and by about 24% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/cervomed-dementia-drug-slows-disease-progression-in-study/choeuj6R5xa">CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Revvity company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’

Healthcare providers are opting for fewer multiplex diagnostic products, the CEO said, while noting that this trend is likely to drive volume for single-plex tests.

Equity

U.S. equities edged up in Monday’s midday trade after President Donald Trump announced the highly anticipated tariff deal with the European Union. Semiconductor stocks also benefited from reports that the Trump administration had temporarily halted restrictions on technology exports to China.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, up 0.04% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq, gained 0.32%.Here are the top stocks making the biggest moves in Monday’s midday trade:<a href="https://stocktwits.com/symbol/TSLA">Tesla Inc. (TSLA)</a>Tesla’s shares extended their surge from Friday and gained nearly 4% in midday trade on Monday after the company announced a $16.5 billion partnership with Samsung Electronics for semiconductor chips.<a href="https://stocktwits.com/symbol/TSLA">TSLA stock</a> is down 19% year-to-date.<a href="https://stocktwits.com/symbol/AMD">Advanced Micro Devices Inc.</a> (AMD),&nbsp;<a href="https://stocktwits.com/symbol/SMCI">Super Micro Computer Inc.</a> (SMCI)AMD stock surged to a fresh 52-week high on Monday, rising more than 4% after the U.S.-EU trade deal established “zero-for-zero” tariffs on semiconductor machinery.SMCI stock surged more than 7%, like some of its other semiconductor peers.Aiding the surge in semiconductor stocks on Monday is a&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.ft.com/content/a13ba438-3b43-46dd-b332-4b81b3644da0">report</a> by the Financial Times stating that the U.S. has temporarily halted restrictions on technology exports to China.<a href="https://stocktwits.com/symbol/AMD">AMD stock</a> is up more than 43% for the year, while the&nbsp;<a href="https://stocktwits.com/symbol/SMCI">SMCI stock</a> is up over 92%.<a href="https://stocktwits.com/symbol/NKE">Nike Inc. (NKE)</a>Nike saw its shares surge nearly 4% on Monday after analysts at JPMorgan&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nike-heads-toward-5-month-highs-after-jpmorgan-upgrade-retail-expects-stock-to-hit-90-mark/choesisR5xe">upgraded the stock</a> to ‘Overweight’ from ‘Neutral,’ citing a potential multi-year recovery.<a href="https://stocktwits.com/symbol/NKE">NKE stock</a> is up nearly 5% for the year.<a href="https://stocktwits.com/symbol/RVTY">Revvity Inc. (RVTY)</a>Revvity shares fell nearly 9% on Monday after the company lowered its earnings outlook for 2025 from $4.9 to $5 per share to $4.85 to $4.95 per share. The company cited a recent regulatory change in China regarding hospital laboratory reimbursement rules, which resulted in a reduction in the overall volumes of its products.<a href="https://stocktwits.com/symbol/RVTY">RVTY stock</a> is down nearly 15% for the year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/firefly-aerospace-fly-ipo-55-b-valuation/choeVfRR5Du">Firefly Aerospace IPO: Space Startup Aims For $5.5B Valuation As Market Debut Nears</a>

A bull statue and a bear statue stand outside the Frankfurt Stock Exchange on April 7, 2025 in Frankfurt, Germany

Tesla, AMD, SMCI, Nike, Revvity: Stocks Making The Biggest Moves Today

Tesla’s shares continued to rise on Monday, extending the surge from Friday after the company announced a $16.5 billion partnership with Samsung Electronics for semiconductor chips.

RVTY Posts Q2 Earnings & Sales Beat, Raises '25 Sales View 

Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.

Revvity (RVTY) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Revvity (RVTY) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates

Revvity (RVTY) delivered earnings and revenue surprises of +3.51% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Revvity (RVTY) is Poised to Beat Earnings Estimates Again

Revvity (RVTY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Revvity Q2 Preview: Can Strong Segments Deliver an Earnings Beat?

RVTY is likely to see another earnings beat as Diagnostics momentum and Signals Software growth offset tariff headwinds.

Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings

Beyond analysts' top-and-bottom-line estimates for Revvity (RVTY), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.

GeneDx Holdings Corp. (WGS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

GENEDX HOLDINGS (WGS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

Revvity (RVTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.

Revvity Inc.

Will the U.S. government shut down in 2025? 
 
*Powered by Polymarket

RVTY
Revvity Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RVTY News

RVTY Revvity Inc.